evenamide (NW-3509) / Newron  >>  Phase 1
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
evenamide (NW-3509) / Newron
NCT01955564: A Phase I- Sequential Cohort Dosing to Determine Maximum Tolerated Dose in Healthy Male Volunteers.

Completed
1
54
US
NW-3509a, NW-3509
Newron Pharmaceuticals SPA
Schizophrenia
09/14
02/15
NCT03446274: An Open Label, Single-Dose Study of 14C-NW-3509 in Healthy Male Subjects

Unknown status
1
6
Europe
Evenamide
Newron Pharmaceuticals SPA
Healthy
04/18
06/18

Download Options